Skip to main content

Change to North Media’s Group Executive Board

Announcement no. 8-2026 22. April 2026 The Board of Directors of North Media has decided to terminate the position as Group Chief Infrastructure and Commercial Optimisation Officer (CICO) and anchor the work with the directors of the Group Executive Board. Ask Illum Jessen will step down from the position as Group Chief Infrastructure and Commercial Optimisation Officer and will resign as member of the Executive Board as of 22. April 2026. Ask will during his notice period work with a number of strategic tasks and projects within the North Media Group. Lasse Ingemann Brodt, Chairman of the Board of Directors says: ”I would like to thank Ask for his work in developing infrastructures across the Group with the aim of achieving optimised productivity and profitability. Furthermore, Ask has been significant in anchoring the sustainability...

Continue reading

Fortuna to release first quarter 2026 financial results on May 6, 2026; Conference call at 12 p.m. Eastern time on May 7, 2026

VANCOUVER, British Columbia, April 22, 2026 (GLOBE NEWSWIRE) — Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) announces that it will release its financial statements and MD&A for the first quarter of 2026 on Wednesday, May 6, 2026, after market close. A conference call to discuss the financial and operational results will be held on Thursday, May 7, 2026, at 9:00 a.m. Pacific time | 12:00 p.m. Eastern time. Hosting the call will be Jorge A. Ganoza, President and CEO, Luis D. Ganoza, Chief Financial Officer, David Whittle, Chief Operating Officer – West Africa, and Cesar Velasco, Chief Operating Officer – Latin America. Shareholders, analysts, media and interested investors are invited to listen to the live conference call by logging onto the webcast at https://www.webcaster5.com/Webcast/Page/1696/53929 or over the...

Continue reading

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS PLC – 21 04 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

StoneX Announces Day-One Access to SHFE Nickel Futures

Largest Non-Bank FCM Providing Entry to China’s Internationalized Exchange-Traded Contracts NEW YORK and SINGAPORE, April 22, 2026 (GLOBE NEWSWIRE) — StoneX Group Inc. (“StoneX”; NASDAQ: SNEX) is now providing clients with day-one access to Nickel futures and options listed on the Shanghai Futures Exchange (SHFE). This announcement comes on the heels of approval of SHFE contracts by the Chinese regulator (CSRC) and marks the first time these contracts have been made available to international participants via the Overseas Intermediary (OI) route. The OI route provides a regulated mechanism through which qualified international participants may access select onshore futures and options contracts. StoneX is the largest non-bank Futures Commission Merchant (FCM) with OI permissions, providing clients with access to onshore Chinese...

Continue reading

Form 8.3 – [ANIMALCARE GROUP PLC – 21 04 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ANIMALCARE GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

HyOrc Successfully Completes Independent Process and Technology Verification for Waste-to-Methanol Platform

HOUSTON, April 22, 2026 (GLOBE NEWSWIRE) — HyOrc Corporation (OTCQB: HYOR) today announced that an independent third-party has successfully validated its RDF-to-methanol pilot methanol synthesis unit at its R&D centre in India. The validation was conducted by Bureau Veritas on April 15, 2026. According to Bureau Veritas Inspection Report No. VET/HYORC/MSW/RDF/METHANOL/TRY/IR-001, the Pilot-Trial achieved a “Satisfactory” result and demonstrated that Refuse-Derived-Fuel (RDF) can be converted into methanol under controlled operating conditions. Methanol was produced and collected for quality verification, with no non-conformities and no punch list items recorded. The trial validated the full process chain, including RDF preparation, gasification, syngas cleaning, methanol synthesis, and methanol condensation, demonstrating end-to-end...

Continue reading

Coop Pank held an investor webinar to introduce unaudited results of Q1 2026

On Wednesday, 22 April 2026 at 9:30 am (EET), Coop Pank held an investor webinar, where the Chairman of the Management Board, Arko Kurtmann, and the Chief Financial Officer, Paavo Truu, introduced the bank’s unaudited financial results of first quarter of 2026. Webinar was held in Estonian language. Coop Pank would like to thank all participants. Webinar recording is available here:https://youtube.com/live/mohkdCfj1Ew. Coop Pank’s report for unaudited results of Q1 2026 and the presentation is available here: https://view.news.eu.nasdaq.com/view?id=1435886&lang=en Coop Pank, based on Estonian capital, is one of the five universal banks operating in Estonia. The bank has 231,000 daily banking clients. Coop Pank aims to put the synergy generated by the interaction of retail business and banking to good use and to bring everyday banking...

Continue reading

Result of the auction of 2.25 per cent DGB 2035 G and 0.25 per cent DGB 2052

Bids, sales, cut-off price, pro rata and yield are presented in the table below:           ISIN Bid mill. DKK (nominal) Sale mill.DKK (nominal) Cut-off price Pro rata Yield99 25182 DGB 2.25% 15/11/2035 G 1,675 1,075 94.89 100 % 2.87 % p.a.99 24029 DGB 0.25% 15/11/2052 3,710 1,500 47.03 33.3 % 3.26 % p.a.Total 5,385 2.575      Settlement: 24 April 2026

Continue reading

Form 8.5 (EPT/NON-RI) – CAB Payments Holdings Plc

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)        Name of exempt principal trader: Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree CAB Payments Holdings Plc(c)        Name of the party to the offer with which exempt principal trader is connected: CAB Payments Holdings Plc(d)        Date dealing undertaken: 21 April 2026(e)        Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? No2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER (a)        Purchases...

Continue reading

Rakovina Therapeutics Presents New Preclinical Data at AACR 2026 Annual Meeting

AI-Designed Dual ATR-mTOR Inhibitor Demonstrates In Vivo Efficacy; Novel LNP Formulation of Bifunctional PARP/HDAC Inhibitor kt-3283 Successfully Characterized VANCOUVER, British Columbia, April 22, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV; FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, today announced the presentation of new preclinical data from two of its lead programs at the 2026 American Association for Cancer Research (AACR) Annual Meeting, held April 17–22 in San Diego, California. The data, presented across two poster sessions at the world’s premier cancer research forum, advance Rakovina’s AI-driven pipeline targeting DNA damage response (DDR) vulnerabilities in hard-to-treat solid tumors. Both programs leverage...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.